183 related articles for article (PubMed ID: 37263018)
1. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
[TBL] [Abstract][Full Text] [Related]
2. A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease.
Lightner AL; Reese J; Ream J; Nachand D; Jia X; Dadgar N; Steele SR; Hull T
Dis Colon Rectum; 2023 Oct; 66(10):1359-1372. PubMed ID: 36602511
[TBL] [Abstract][Full Text] [Related]
3. A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's disease.
Lightner AL; Reese JS; Ream J; Nachand D; Dadgar N; Adams A; VanDenBossche A; Pineiro AO; Hull T
Surgery; 2024 Feb; 175(2):242-249. PubMed ID: 37661485
[TBL] [Abstract][Full Text] [Related]
4. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
Lightner AL; Reese J; Ream J; Nachand D; Jia X; Pineiro AO; Dadgar N; Steele S; Hull T
J Crohns Colitis; 2023 Apr; 17(4):480-488. PubMed ID: 36322714
[TBL] [Abstract][Full Text] [Related]
5. Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
Dozois EJ; Lightner AL; Dietz AB; Fletcher JG; Lee YS; Friton JJ; Faubion WA
Dis Colon Rectum; 2023 Feb; 66(2):243-252. PubMed ID: 36538706
[TBL] [Abstract][Full Text] [Related]
6. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Garcia-Olmo D; Gilaberte I; Binek M; D Hoore AJL; Lindner D; Selvaggi F; Spinelli A; Panés J
Dis Colon Rectum; 2022 May; 65(5):713-720. PubMed ID: 34890373
[TBL] [Abstract][Full Text] [Related]
7. Direct Injection of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Crohn's Perianal Fistulizing Disease.
Lightner AL; Kurowski J; Otero-Pinerio AM
Dis Colon Rectum; 2024 Feb; 67(2):e115-e116. PubMed ID: 37728573
[No Abstract] [Full Text] [Related]
8. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É
J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215
[TBL] [Abstract][Full Text] [Related]
9. Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up.
Keung C; Nguyen TC; Lim R; Gerstenmaier A; Sievert W; Moore GT
EBioMedicine; 2023 Dec; 98():104879. PubMed ID: 38042747
[TBL] [Abstract][Full Text] [Related]
10. Comments on: "A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone-Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease".
Cheng F
Dis Colon Rectum; 2024 Mar; 67(3):e202. PubMed ID: 38063466
[No Abstract] [Full Text] [Related]
11. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
[TBL] [Abstract][Full Text] [Related]
14. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
Meng ZW; Baumgart DC
Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
[TBL] [Abstract][Full Text] [Related]
15. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study.
Wei J; Zhang Y; Chen C; Feng X; Yang Z; Feng J; Jiang Q; Fu J; Xuan J; Gao H; Liao L; Wang F
Stem Cell Res Ther; 2023 Oct; 14(1):311. PubMed ID: 37904247
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.
Dawoud C; Widmann KM; Czipin S; Pramhas M; Scharitzer M; Stift A; Harpain F; Riss S
Wien Klin Wochenschr; 2024 May; 136(9-10):289-294. PubMed ID: 37823920
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn's Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons.
Williams P; Klersy C; Karki C; Bennett D; Rodríguez AM; Ciccocioppo R
Adv Ther; 2022 Jun; 39(6):2761-2777. PubMed ID: 35426592
[TBL] [Abstract][Full Text] [Related]
20. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
